Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
has not received a second dose yet; This non-serious case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a 38-year-old female patient who received HBV (Engerix B) for prophylaxis. Previously administered products included Engerix-B (received 1st dose of vaccine in 2016). On an unknown date, the patient did not receive the 2nd dose of Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced incomplete course of vaccination (Verbatim: has not received a second dose yet). The outcome of the incomplete course of vaccination was unknown. Additional Information: GSK Receipt Date: 06-FEB-2025 Reporter called to report in 2016 a patient received a first dose of Engerix-B and has not received a second dose yet. Till the time of reporting, the patient did not receive 2nd dose of Engerix-B, which led to incomplete course of vaccination.